Phung Tu Gip

Title: Phung Tu Gip: Innovator in Engineered Polypeptides

Introduction

Phung Tu Gip is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. With a total of two patents to her name, her work has the potential to impact therapeutic approaches in treating various diseases.

Latest Patents

Phung Tu Gip's latest patents include "Engineered CD25 polypeptides and uses thereof." This patent provides engineered polypeptides that incorporate spatially-associated topological constraints, with at least one constraint derived from a CD25 reference target. The patent outlines methods for selecting these engineered polypeptides and their applications as positive and/or negative selection molecules in screening libraries of binding molecules, such as antibodies. Additionally, her work on CD25 antibodies details antibodies that specifically bind to CD25, along with methods for their production and therapeutic uses. These antibodies may be utilized to treat cancer or autoimmune diseases, showcasing their potential in medical applications.

Career Highlights

Phung Tu Gip is currently associated with Ibio Limited, where she continues to advance her research and innovations. Her work is characterized by a strong focus on the intersection of biotechnology and therapeutic development.

Collaborations

Phung collaborates with esteemed colleagues, including Matthew Paul Greving and Mohan Srinivasan, contributing to a dynamic research environment that fosters innovation.

Conclusion

Phung Tu Gip's contributions to the field of engineered polypeptides highlight her role as a leading inventor in biotechnology. Her patents not only advance scientific knowledge but also hold promise for future therapeutic applications.